<DOC>
	<DOCNO>NCT01635114</DOCNO>
	<brief_summary>The purpose study investigate effect antioxidant `` resveratrol '' liver fat content , body-composition insulin sensitivity Resveratrol find grape skin , wine , peanut , mulberry think health benefit improve fat metabolism , insulin action , possibly extend lifespan . resVida™ name dietary supplement contain natural antioxidant `` resveratrol '' . resVida™ supplied DSM Nutritional Products , Ltd. resVida™ consider dietary supplement , therefore approve drug German Authority . It regulate like food . The maker resVida™ make claim supplement mean treat ailment . This study design investigate health benefit resveratrol .</brief_summary>
	<brief_title>Effect resVida Liver Fat Content</brief_title>
	<detailed_description />
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Resveratrol</mesh_term>
	<criteria>Gender : male female Age : 18 year 70 year ( inclusive ) Overweight obese ( BMI ≥ &gt; 27 mg/kg2 ) HOMAIR ≥ &gt; 2.0 Negative urine pregnancy test Acceptable take oral contraceptive pill method birth control ( surgical sterility , double barrier method , intrauterine contraceptive device , lifestyle personal choice abstinence , vasectomy sexual partner least 3 month prior enrolment combination barrier method ) Willingness ability give write informed consent willingness ability understand , participate comply study requirement . Subjects liver cirrhosis Subjects liver disease diagnosis ( e.g . know M. Wilson , autoimmune hepatitis , primary sclerosing cholangitis ) Subjects diagnose diabetes Current pregnancy breast feeding ( determined pregnancy test ) ; postmenopausal woman take oral hormone therapy . Delivery within last year Changes dose initiation lipid alter medication within precede three month , statin , fibrates systemic steroid Significant comorbid inflammatory illness rheumatoid arthritis , chronic bowel disease , sarkoidosis etc . Contraindications MR scan claustrophobia , cardiac pacemaker , ferromagnetic haemostatic clip central nervous system , metallic splinter eye , automatic cardioverter defibrillator , prosthetic heart valve , cochlear implant , insulin pump nerve stimulators , etc . fit MR machine due severe adiposity Subjects medical condition judge investigator likely interfere evaluation subject 's safety study outcome . Subjects abnormality safety profile judge investigator clinically significant . Subjects ALT AST &gt; 2.5x upper reference limit ( 50 U/L respectively ) Subjects treatment drug strongly metabolize via CYP3A4 ( e.g . alfentanil , astemizole , cisapride , cyclosporine , diergotamine , ergotamine , fentanyl , irinotecan , pimozide , quinidine , sirolimus , tacrolimus , terfenadine ) CYP2C9 ( e.g . Phenytoin Warfarin ) Smokers ( &gt; 10 cigarette per day ) Regular drinker than15g /day ( e.g wine ( 0,1 l ) , 1 beer ( 0,33 l ) History , current evidence , abuse alcohol drug substance , licit illicit . Intake overthecounter ( OTC ) medication dietary supplement ( except occasional paracetamol/aspirin , multivitamin supplement ) duration study . Poor compliers subject unlikely attend . Receipt investigational product ( e.g. , drug , supplement , dietary intervention ) part research study within 30 day initial dose administration study . Blood donation ( usually 550 ml ) within 12 week period initial study dose .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>